Ebola Treatment Trial Commences in DRC's Ituri Region
The first patients have been enrolled in an Ebola treatment trial in the Ituri region of the Democratic Republic of the Congo (DRC). The trial, which involves two investigational drugs, aims to reduce the high mortality rates associated with the disease. Scientists note that the program was established at a record pace, launching just six weeks after the outbreak was declared a public health emergency of international concern by the World Health Organization (WHO) on May 17.
A new treatment trial for Ebola has begun in the Ituri region of the Democratic Republic of the Congo (DRC), with the first patients now enrolled. This program is testing two different drugs in an effort to develop an approved treatment for the deadly virus, which currently lacks a specific cure.
Medical teams in the DRC are working to save lives amid the current Ebola outbreak. Researchers hope that the drugs being trialled will significantly reduce mortality rates among those infected.
Scientists have highlighted the rapid establishment of the trial, describing it as a record pace for such research. Patients were enrolled approximately six weeks after the World Health Organization (WHO) designated the outbreak as a public health emergency of international concern on May 17.
According to The Guardian World, the swift initiation of the trial offers hope that an approved drug could become available within months.
